Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

Neuron

Volumn 65, Issue 1, 2010, Pages 66-79

  Nemani, Venu M ^a   Lu, Wei ^b   Berge, Victoria ^c   Nakamura, Ken ^a   Onoa, Bibiana ^a   Lee, Michael K ^d   Chaudhry, Farrukh A ^c   Nicoll, Roger A ^b   Edwards, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cellbio; molneuro

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; GENE DUPLICATION; MOUSE; NERVE CELL LESION; NEUROLOGIC DISEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SYNAPSE VESICLE; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; ULTRASTRUCTURE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALPHA-SYNUCLEIN; ANIMALS; CELLS, CULTURED; DOPAMINE; ENDOCYTOSIS; EXOCYTOSIS; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE; RECOMBINANT FUSION PROTEINS; SYNAPSINS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 73549085595     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2009.12.023     Document Type: Article

References (74)

1. Abeliovich A., Schmitz Y., Fariñas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000) 239-252
2. Augustin I., Korte S., Rickmann M., Kretzschmar H.A., Südhof T.C., Herms J.W., and Brose N. The cerebellum-specific Munc13 isoform Munc13-3 regulates cerebellar synaptic transmission and motor learning in mice. J. Neurosci. 21 (2001) 10-17
3. Banker G., and Goslin K. Culturing Nerve Cells. second edition (1998), MIT Press, Cambridge, MA
4. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003) 197-211
5. Bussell Jr. R., and Eliezer D. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329 (2003) 763-778
6. Bussell Jr. R., and Eliezer D. Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein. Biochemistry 43 (2004) 4810-4818
7. Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.L., Orrison B., Chen A., Ellis C.E., Paylor R., et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22 (2002) 8797-8807
8. Chandra S., Fornai F., Kwon H.B., Yazdani U., Atasoy D., Liu X., Hammer R.E., Battaglia G., German D.C., Castillo P.E., and Südhof T.C. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc. Natl. Acad. Sci. USA 101 (2004) 14966-14971
9. Chandra S., Gallardo G., Fernández-Chacón R., Schlüter O.M., and Südhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123 (2005) 383-396
10. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364 (2004) 1167-1169
11. Chen L., and Feany M.B. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. 8 (2005) 657-663
12. Chiba-Falek O., Lopez G.J., and Nussbaum R.L. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov. Disord. 21 (2006) 1703-1708
13. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006) 324-328
14. Dal Bo G., St-Gelais F., Danik M., Williams S., Cotton M., and Trudeau L.E. Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J. Neurochem. 88 (2004) 1398-1405
15. Davidson W.S., Jonas A., Clayton D.F., and George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273 (1998) 9443-9449
16. Dickson D.W. Alpha-synuclein and the Lewy body disorders. Curr. Opin. Neurol. 14 (2001) 423-432
17. Ellis C.E., Schwartzberg P.L., Grider T.L., Fink D.W., and Nussbaum R.L. alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J. Biol. Chem. 276 (2001) 3879-3884
18. Ferguson S.M., Brasnjo G., Hayashi M., Wolfel M., Collesi C., Giovedi S., Raimondi A., Gong L.W., Ariel P., Paradise S., et al. A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science 316 (2007) 570-574
19. Fernández-Chacón R., Wölfel M., Nishimune H., Tabares L., Schmitz F., Castellano-Muñoz M., Rosenmund C., Montesinos M.L., Sanes J.R., Schneggenburger R., and Südhof T.C. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron 42 (2004) 237-251
20. Fortin D.L., Troyer M.D., Nakamura K., Kubo S., Anthony M.D., and Edwards R.H. Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24 (2004) 6715-6723
21. Fortin D.L., Nemani V.M., Voglmaier S.M., Anthony M.D., Ryan T.A., and Edwards R.H. Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci. 25 (2005) 10913-10921
22. Fredenburg R.A., Rospigliosi C., Meray R.K., Kessler J.C., Lashuel H.A., Eliezer D., and Lansbury Jr. P.T. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Biochemistry 46 (2007) 7107-7118
23. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., and Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4 (2002) 160-164
24. George J.M., Jin H., Woods W.S., and Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15 (1995) 361-372
25. Giasson B.I., Duda J.E., Quinn S.M., Zhang B., Trojanowski J.Q., and Lee V.M. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34 (2002) 521-533
26. Gitler A.D., Bevis B.J., Shorter J., Strathearn K.E., Hamamichi S., Su L.J., Caldwell K.A., Caldwell G.A., Rochet J.C., McCaffery J.M., et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA 105 (2008) 145-150
27. Haass C., and Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8 (2007) 101-112
28. Hashimoto M., Rockenstein E., Mante M., Mallory M., and Masliah E. beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 32 (2001) 213-223
29. Hilfiker S., Pieribone V.A., Czernik A.J., Kao H.T., Augustine G.J., and Greengard P. Synapsins as regulators of neurotransmitter release. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354 (1999) 269-279
30. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., and Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 (1995) 467-475
31. Jo E., Fuller N., Rand R.P., St George-Hyslop P., and Fraser P.E. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J. Mol. Biol. 315 (2002) 799-807
32. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
33. Krüger R., Kuhn W., Leenders K.L., Sprengelmeyer R., Müller T., Woitalla D., Portman A.T., Maguire R.P., Veenma L., Schröder U., et al. Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology 56 (2001) 1355-1362
34. Kubo S., Nemani V.M., Chalkley R.J., Anthony M.D., Hattori N., Mizuno Y., Edwards R.H., and Fortin D.L. A combinatorial code for the interaction of alpha-synuclein with membranes. J. Biol. Chem. 280 (2005) 31664-31672
35. Larsen K.E., Schmitz Y., Troyer M.D., Mosharov E., Dietrich P., Quazi A.Z., Savalle M., Nemani V., Chaudhry F.A., Edwards R.H., et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26 (2006) 11915-11922
36. Lee M.K., Stirling W., Xu Y., Xu X., Qui D., Mandir A.S., Dawson T.M., Copeland N.G., Jenkins N.A., and Price D.L. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 -> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. USA 99 (2002) 8968-8973
37. Li H., Waites C.L., Staal R.G., Dobryy Y., Park J., Sulzer D.L., and Edwards R.H. Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines. Neuron 48 (2005) 619-633
38. Lu W., Shi Y., Jackson A.C., Bjorgan K., During M.J., Sprengel R., Seeburg P.H., and Nicoll R.A. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron 62 (2009) 254-268
39. Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., and Di Monte D.A. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci. 23 (2003) 3095-3099
40. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Krüger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., et al., Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296 (2006) 661-670
41. Maroteaux L., Campanelli J.T., and Scheller R.H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8 (1988) 2804-2815
42. Matsuoka Y., Vila M., Lincoln S., McCormack A., Picciano M., LaFrancois J., Yu X., Dickson D., Langston W.J., McGowan E., et al. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol. Dis. 8 (2001) 535-539
43. McFarland M.A., Ellis C.E., Markey S.P., and Nussbaum R.L. Proteomic analysis identifies phosphorylation-dependent a-synuclein protein interactions. Mol. Cell Proteomics. 7 (2008) 2123-2137
44. Mena M.A., Khan U., Togasaki D.M., Sulzer D., Epstein C.J., and Przedborski S. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J. Neurochem. 69 (1997) 21-33
45. Miesenböck G., De Angelis D.A., and Rothman J.E. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394 (1998) 192-195
46. Miller D.W., Hague S.M., Clarimon J., Baptista M., Gwinn-Hardy K., Cookson M.R., and Singleton A.B. Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62 (2004) 1835-1838
47. Mozhayeva M.G., Sara Y., Liu X., and Kavalali E.T. Development of vesicle pools during maturation of hippocampal synapses. J. Neurosci. 22 (2002) 654-665
48. Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., Meijer L., Kahle P.J., and Haass C. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem. 275 (2000) 390-397
49. Outeiro T.F., and Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302 (2003) 1772-1775
50. Park J.Y., and Lansbury Jr. P.T. Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. Biochemistry 42 (2003) 3696-3700
51. Park S.M., Jung H.Y., Kim H.O., Rhim H., Paik S.R., Chung K.C., Park J.H., and Kim J. Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets. Blood 100 (2002) 2506-2514
52. Payton J.E., Perrin R.J., Woods W.S., and George J.M. Structural determinants of PLD2 inhibition by alpha-synuclein. J. Mol. Biol. 337 (2004) 1001-1009
53. Petrucelli L., O'Farrell C., Lockhart P.J., Baptista M., Kehoe K., Vink L., Choi P., Wolozin B., Farrer M., Hardy J., and Cookson M.R. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36 (2002) 1007-1019
54. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
55. Pyle J.L., Kavalali E.T., Piedras-Rentería E.S., and Tsien R.W. Rapid reuse of readily releasable pool vesicles at hippocampal synapses. Neuron 28 (2000) 221-231
56. Quilty M.C., King A.E., Gai W.P., Pountney D.L., West A.K., Vickers J.C., and Dickson T.C. Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp. Neurol. 199 (2006) 249-256
57. Rosahl T.W., Geppert M., Spillane D., Herz J., Hammer R.E., Malenka R.C., and Südhof T.C. Short-term synaptic plasticity is altered in mice lacking synapsin I. Cell 75 (1993) 661-670
58. Rosahl T.W., Spillane D., Missler M., Herz J., Selig D.K., Wolff J.R., Hammer R.E., Malenka R.C., and Südhof T.C. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375 (1995) 488-493
59. Rosenmund C., and Stevens C.F. Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16 (1996) 1197-1207
60. Ryan T.A., Li L., Chin L.S., Greengard P., and Smith S.J. Synaptic vesicle recycling in synapsin I knock-out mice. J. Cell Biol. 134 (1996) 1219-1227
61. Senior S.L., Ninkina N., Deacon R., Bannerman D., Buchman V.L., Cragg S.J., and Wade-Martins R. Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. Eur. J. Neurosci. 27 (2008) 947-957
62. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
63. Smith W.W., Margolis R.L., Li X., Troncoso J.C., Lee M.K., Dawson V.L., Dawson T.M., Iwatsubo T., and Ross C.A. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J. Neurosci. 25 (2005) 5544-5552
64. Soper J.H., Roy S., Stieber A., Lee E., Wilson R.B., Trojanowski J.Q., Burd C.G., and Lee V.M. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell 19 (2008) 1093-1103
65. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. USA 95 (1998) 6469-6473
66. Sudhof T.C., and Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 323 (2009) 474-477
67. Sulzer D., Joyce M.P., Lin L., Geldwert D., Haber S.N., Hattori T., and Rayport S. Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci. 18 (1998) 4588-4602
68. Uversky V.N., Li J., Souillac P., Millett I.S., Doniach S., Jakes R., Goedert M., and Fink A.L. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J. Biol. Chem. 277 (2002) 11970-11978
69. Vila M., Vukosavic S., Jackson-Lewis V., Neystat M., Jakowec M., and Przedborski S. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem. 74 (2000) 721-729
70. Voglmaier S.M., Kam K., Yang H., Fortin D.L., Hua Z., Nicoll R.A., and Edwards R.H. Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling. Neuron 51 (2006) 71-84
71. Willingham S., Outeiro T.F., DeVit M.J., Lindquist S.L., and Muchowski P.J. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302 (2003) 1769-1772
72. Yavich L., Tanila H., Vepsalainen S., and Jakala P. Role of alpha-synuclein in presynaptic dopamine recruitment. J. Neurosci. 24 (2004) 11165-11170
73. Zarranz J.J., Alegre J., Gómez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2004) 164-173
74. Zhou W., Hurlbert M.S., Schaack J., Prasad K.N., and Freed C.R. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866 (2000) 33-43